Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism β-lactamase inhibitors(Beta Lactamase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H19N5Na2O7S2 |
InChIKeyQUWLUSTXMPSFMY-GCOZZYQZSA-N |
CAS Registry225656-15-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bacterial Infections | Preclinical | KR | 01 Oct 1998 |